The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy

Solinas, C; Gu-Trantien, C; Willard-Gallo, K

ESMO OPEN, 2020; 5 (1):

Abstract

Inducible T cell costimulator (ICOS, cluster of differentiation (CD278)) is an activating costimulatory immune checkpoint expressed on activated T cel......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索